Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)

Author(s)

• MI

  Matthew A. Ingham, MD

  Assistant Professor of Medicine Division of Hematology and Oncology
  New York Presbyterian Hospital/Columbia University Medical Center
  New York, New York, United States

  Slides PDF

Co-Author(s)

• JH

  James S. Hu, MD

  Clinical Associate Professor of Medicine (Clinician Educator)
  University of Southern California Norris Comprehensive Cancer Center
  Los Angeles, California, United States
• 

  Giles Francis Whalen, MD

  Chief, Division of Surgical Oncology; Professor
  University of Massachusetts Memorial Medical Center,
  Worcester, Massachusetts, United States
• JT

  Jacob Thomas, MD

  Assistant Professor of Clinical Medicine
  University of Southern California Norris Comprehensive Cancer Center
  Huntington Beach, California, United States
• AE

  Anthony B. El-Khoueiry, MD

  Associate Professor of Medicine
  University of Southern California Norris Comprehensive Cancer Center
  Los Angeles, California, United States
• 

  Diana Hanna, MD

  Assistant Professor of Clinical Medicine
  USC Norris Comprehensive Cancer Center
  Los Angeles, California, United States
• AO

  Anthony Olszanski, MD

  Vice Chair, Associate Professor, Department of Hematology/Oncology
  Johns Hopkins Sidney Kimmel Cancer Center
  Baltimore, Maryland, United States
• CM

  Christian F. Meyer, MD, PhD

  Assistant Professor of Oncology
  Johns Hopkins Sidney Kimmel Cancer Center
  Baltimore, Maryland, United States
• NA

  Nilofer S. Azad, MD

  Associate Professor of Oncology
  Johns Hopkins Sidney Kimmel Cancer Center
  Baltimore, Maryland, United States
• LC

  Luis Camacho, MD

  Center for Oncology and Blood Disorders
  Houston, Texas, United States
• 

  Lewis Bender, MS (he/him/his)

  CEO
  Intensity Therapeutics
  Westport, Connecticut, United States
• LS

  Lillian L. Siu, MD

  Professor of Medicine
  Princess Margaret Cancer Centre, University Health Network
  Toronto, Ontario, Canada
• 

  Albiruni Ryan Abdul Razak, MB, MRCPI (he/him/his)

  Staff Medical Oncologist, Solid Tumor Program and Medical Oncology Lead, Sarcoma Program
  Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto; Department of Medical Oncology, Mount Sinai Hospital
  Toronto, Ontario, Canada
• IW

  Ian B. Walters, MD

  CMO
  Intensity Therapeutics
  Westport, Connecticut, United States